Subscribe to NRx Newsletter

Events

Sachs Neuroscience Innovation Forum
 Sunday, January 7, 2024

NRx Pharmaceuticals, Inc. gave the keynote address entitled "Ketamine for Suicidal Depression: The Benefits are Clear, But So are the Risks," at the Sachs Neuroscience Innovation Forum at the Marines' Memorial Club in San Francisco, CA on January 7, 2024.

Watch the keynote address here.

Read the keynote address transcript here.

Corporate Presentation

Click here to view our corporate presentation or on the image below

Bottom Global Links (above footer)